Sales & Marketing
Why a healthy search strategy can power pharma brand growth
‘Cyber-chondria’ has become an endemic part of our daily lives since …
20115 items found
News
Novartis sheds MorphoSys staff, sites after pelabresib delay
Novartis has said it will shut down two MorphoSys sites in Germany …
News
Vertex weakens after neuropathic pain trial reads out
Vertex Pharma's non-opioid painkiller suzetrigine was unable to …
News
Neuralink rival Precision raises $102m, and other financings
Precision Neurosciences has closed an impressive $102 million …
News
Roche's Parkinson's hope fails second clinical trial
An experimental therapy for Parkinson's disease being developed by …
News
Novo completes $16.5bn takeover of Catalent
Novo Holdings' $16.5 billion acquisition of US contract development …
News
Ottimo raises $140m for its PD-1/VEGF cancer drug
Anglo-US biotech Ottimo Pharma has completed a big early-stage …
R&D
How small molecule-focused CDMOs can navigate the impact of the Inflation Reduction Act
As large-molecule drugs and weight-loss therapeutics dominate …
News
MSD makes its obesity move with $2bn Hansoh deal
MSD has been rumoured to be considering a takeover of Viking …
News
Mesoblast finally pushes GvHD cell therapy over finish line
At its third attempt, Mesoblast has secured FDA approval for Ryoncil …
R&D
Sponsored
Innovative sublingual medication for improved stroke care
Stroke poses a major threat to public health, and this threat is …
R&D
Precision medicine, NGS, and the quantum leap in biomarkers
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with …
Market Access
The biopharma outlook for 2025: Opportunities and challenges
With the Federal Reserve poised to implement interest rate cuts (albeit fewer than earlier forecasts assumed) and FTC leadership turnover anticipated, there may be broader shifts in how cap
Sales & Marketing
Sponsored
Health Trends 2025: Reimagining What's Possible
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
Digital
Deep Dive: AI 2024
In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and
Spotlight on
World Without Disease initiative: 2024 update
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year
R&D
Precision medicine, NGS, and the quantum leap in biomarkers
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
Partner Content
hubXchange returns with its latest series of roundtables!
hubXchange invites you to participate in its highly-anticipated San Diego Series 2025, a series of focused, high-level roundtable events designed to address key challenges and innovations across th
R&D
Partner Content
Advance Best-In-Class Treatment Across CNS, Emergency Use Tr...
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics.
